Alcohol metabolism


Key Point

Ethanol metabolism increase NADH/NAD+, which further downregulate gluconeogenesis and TCA cycle, and increase lactate.

Pasted image 20240224210805.pngPasted image 20240224211402.png

Mnemonic

  • Fomepizole: think it as Foam-epizole, which can turn the beer to a lot of foam and less liquid (dehydro).
    • Used for alcohol intoxication
  • Disulfiram: diSUFFERam. It can increase acetaldehyde and make people sick and dizzy.
    • Used in alcohol use disorder, as 2nd line treatment

Pasted image 20240224213058.png

Treatment


Pharmacotherapy

First-line options

  • Naltrexone and acamprosate are preferred.
    • Naltrexone: central μ-opioid receptor antagonist
    • Acamprosate: may modulate central glutamate receptors
  • Both medications reduce cravings and can be used for patients who:
    • Continue to drink alcohol
    • Use other substances recreationally

Alternative options

  • Disulfiram
  • Topiramate
  • Gabapentin

Complications


Multisystem complications

Alcohol intoxication


Pathophysiology

  • Mechanism
    • GABA-A receptor agonist → Chronic use causes downregulation of GABA-A receptors → decreased GABA-A activity when cessation
    • NMDA glutamate antagonist → chronic use causes upregulation of NMDA receptors → increased glutamate NMDA activity when cessation
  • Absorption: The majority of alcohol consumed is absorbed by the proximal small intestine; only a small amount of alcohol is absorbed by the oral, esophageal, and/or gastric mucosa.

Clinical features

Altered consciousness, cognition, perception, judgment, affect, and/or behavior.

Diagnostics

  • Routine laboratory studies that support the diagnosis include:
    • Elevated osmolar gap
      • The difference between the measured serum osmolarity and the calculated serum osmolarity. Normally, the calculated serum osmolarity is primarily determined by circulating levels of sodium salts (chloride and bicarbonate), glucose, and urea. An increased serum osmolar gap occurs when other solutes (e.g., ethanol, methanol, propylene glycol) are present in high enough concentrations to increase the measured osmolarity by more than 10 mOsmol/L.
    • Anion gap metabolic acidosis (e.g., ↓ pH, ↓ HCO3-)

Treatment

Alcohol dehydrogenase inhibitors

  • Goal: to prevent the conversion of methanol or ethylene glycol to toxic metabolites (e.g., formic acid, glycolic acid, oxalic acid) by competitively inhibiting alcohol dehydrogenase
  • Options
    • Fomepizole (first-line): a competitive alcohol dehydrogenase inhibitor; safer and easier to administer than ethanol
    • Ethanol (second-line)